Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans.
The research, published in Scientific Reports, also highlights the role of lipid metabolism in maintaining the health of the retina, reporting that palmitoleic acid also had protective effects on retinal cells in culture and in mice.
The “good-for-you” compound in broccoli which prompted the inquiry is indole-3-carbinol (I3C), which is currently being studied for cancer prevention. I3C helps clear cells of environmental toxins by activating the aryl hydrocarbon receptor (AhR) protein which upregulates pathways involved in chemical detoxification. AhR, which declines with age, is important for detoxifying the retina. Previous studies show that AhR-deficient mice develop a condition which looks extremely similar to AMD. When contemplating the possibility of boosting AhR via broccoli’s I3C, Buck faculty and lead author Arvind Ramanathan, PhD, knew there was a challenge – I3C is weak activator of AhR. So he used the chemical scaffold of I3C to do a ‘virtual’ screen of a publicly-available database of millions of compounds to find those that were related to I3C but would bind to AhR with more strength. His team came up with 2,2?-aminophenyl indole (2AI) which is ten times more potent than I3C.
“2AI protected human retinal cells in culture from stress,” said Ramanathan. “And it also protected retinal cells in mice from light-mediated damage. We are very excited about the potential for 2AI and look forward to developing it further.” Ramanathan is also excited about the possibility of finding more potent versions of other naturally occurring molecules that show health benefits for age-related diseases. “You would have to eat an unreasonable amount of broccoli and other cruciferous vegetables to get enough of a protective effect to impact AMD,” he said. “This method allows us to capitalize on nature’s wisdom to find related molecules that can deliver therapeutic benefit.”
“2AI prevented cell death in the retinas of mice that were exposed to light stress,” said Buck faculty and co-senior author Deepak Lamba, MBBS, PhD, who is developing stem-cell based therapies for degenerative eye diseases. “Our next step is to study the functional outcomes of treatment with 2AI, something I am eager to do because environmental stress is the major contributor to age-related vision loss.”
Ramanathan said data from the study suggests that at least some of the protective effects of the AhR activation may come via lipids. “We know that eating a diet rich in fish and omega fatty acids reduces the risk of AMD, even though we don’t fully understand the mechanisms involved.” Ramanathan said in this study, 2AI increased levels of the omega-7 lipid palmitoleic acid (PA) suggesting it could be a downstream signal in the anti-inflammatory pathway. Ramanathan said injecting PA also had protective effects on retinal cells in culture and in mice. PA is found in a variety of food including nuts, fish, dairy and vegetable oils. It is found at high concentrations in macadamia and sea buckthorn oil.
The Latest on: Age-related macular degeneration
via Google News
The Latest on: Age-related macular degeneration
- Graybug Vision Announces Full Year 2020 Financial Results and Recent Corporate Developmentson March 4, 2021 at 2:39 pm
Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today ...
- Air pollution linked to increased chance of macular degenerationon March 3, 2021 at 5:24 am
People living in highly polluted areas are 8% more likely to get AMD according to a study from the British Journal of Ophthalmology ...
- Iveric Bio Reports Fourth Quarter and Year End 2020 Operational Highlights and Financial Resultson March 3, 2021 at 5:00 am
IVERIC bio, Inc. today announced financial and operating results for the fourth quarter and full year ended December 31, 2020 and provided a general business update. “We start 2021 with significant ...
- Are You at Risk for Macular Degeneration?on March 2, 2021 at 3:15 pm
If you’re over 65 and of European descent, you could be at risk for macular degeneration, the leading cause of age-related vision loss. Yet lifestyle choices can help to slow the disease’s progression ...
- Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profileon March 2, 2021 at 2:57 am
Choroidal changes have been suggested to be involved in the pathophysiology of both age-related macular degeneration (AMD) and pachychoroid spectrum diseases (PSD). To find out the choroidal ...
- Research points to new hope for treatment-resistant age-related macular degenerationon March 1, 2021 at 4:51 am
An oxysterol that accumulates in the eye with age can transform choroidal endothelial cells; interfering with the process might help patients with treatment-resistant age-related macular degeneration.
- Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degenerationon February 26, 2021 at 6:55 am
To investigate sensitive outcome measures based exclusively on abnormal points in microperimetry testing of eyes with intermediate age-related macular degeneration (iAMD). 25 eyes of 25 subjects with ...
- Health Watch: Age Related Macular Degeneration is highlighted for Low Vision Awareness Monthon February 24, 2021 at 5:11 pm
There are certain types of vision loss that can’t be simply solved with a pair of lenses. February is the National Eye Institute’s Low Vision Awareness Month, a campaign designed to educate the nation ...
- Stealth BioTherapeutics Completes Enrollment of Phase 2 Study in Dry Age-Related Macular Degeneration with Geographic Atrophyon February 22, 2021 at 10:30 pm
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial ...
- Scientists find new therapeutic approach to effectively treat age-related macular degenerationon February 22, 2021 at 4:48 pm
Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy.
via Bing News